Everyday Health on MSN
Rheumatoid Arthritis in Men: What’s Different?
Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...
MedPage Today on MSN
Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief
Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...
MedPage Today on MSN
Phone Data May Give Early Warning on Rheumatoid Arthritis Flares
Rheumatoid arthritis patients often don't notice disease flares until symptoms have already worsened substantially. As joint ...
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
GlobalData on MSN
Lynk’s selective JAK inhibitor claims Phase III RA win
Lynk’s zemprocitinib commercial partner, Simcere, will now continue the JAK inhibitor’s development across China in RA.
Medically reviewed by Stella Bard, MD Osteoarthritis occurs when joint cartilage breaks down over time, causing pain and stiffness.Rheumatoid arthritis is an autoimmune disease where the immune system ...
Juvenile idiopathic arthritis and rheumatoid arthritis are both inflammatory diseases that affect the joints, but they’re separate conditions with unique long-term outlooks. The most common type of ...
Rheumatoid arthritis (RA) commonly causes fatigue and pain, stiffness, and swelling in your joints. Roughly 40% of people also experience one or more symptoms in areas outside the joint. These ...
A national cohort study shows rheumatoid arthritis remission rates in England and Wales have plateaued since 2018, with wide ...
FODMAP Everyday® on MSN
Arthritis isn’t fair: Why women take the hardest hit
Women are disproportionately affected by almost every major form of arthritis, and the gap isn’t small. The pattern shows up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results